Show results for
Refine by
Locations
- USA
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia (Us)
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Chronic Heart Failure Suppliers In Usa
10 companies found
based inMoorpark, CALIFORNIA (USA)
Based in Moorpark, California, ForaCare Inc. US is a healthcare technology company dedicated to the design and development of products for chronic disease management. The aim of ForaCare Inc. is to complete the cycle of chronic disease management by ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Levosimendan (Simsndan; OR-1259) is a calcium sensitiser used in the management of acutely decompensated congestive heart ...
based inCaesarea Industrial Park (N), ISRAEL
V-WAVE was established in Israel in 2009 with a focus on developing percutaneous implantable technologies for patients with chronic heart failure. Technology designed by V-Wave, highlighted by its Ventura Interatrial Shunt System, was designed to ...
based inSan Francisco, CALIFORNIA (USA)
ViCardia Therapeutics, Inc., a Delaware corporation, founded in 2017, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies for treating heart failure (HF) involving ...
ViCardia is entering Phase 2 with GP531, a potent, long-lasting, infusion therapy that treats mitochondrial dysfunction that leads to chronic heart failure and ultimately to acute decompensated ...
based inWayne, PENNSYLVANIA (USA)
XyloCor Therapeutics is a biopharmaceutical company focused on the development of novel gene therapy for unmet needs in advanced coronary artery disease. In the United States, coronary artery disease is a leading cause of death and disability. Our ...
based inHouston, TEXAS (USA)
Millar is known as a leader in the innovation of MEMS sensor-enabled devices from mouse to man, enabling medical advancements from heart failure research in mice to providing clinical pressure feedback data through integrated medical devices. With ...
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
Mesoblast has a strong and extensive global intellectual property (IP) portfolio with protection extending through to at least 2040 in all major markets. This IP position is expected to provide the Company with substantial commercial advantages as ...
based inReno, NEVADA (USA)
Accelerated Care Plus (ACP) was founded more than 20 years ago - with one goal in mind - to get Your Patients Better, Faster. Our Evidence-based Clinical Programs combine the most advanced Rehabilitation Technologies and Clinical Services, including ...
The next step in balance training, the OmniStand® dynamic balance system gives therapists the freedom to work with individual patients to provide effective, progressive balance and gait-training. This fall-safe system provides adjustable, ...
based inMarlton, NEW JERSEY (USA)
Impulse Dynamics is a fast-growing medical device company that has pioneered a new form of therapy for heart failure called Cardiac Contractility Modulation, or CCM TM, which is delivered by the company’s Optimizer Smart System. CCM is ...
based inBurlington, MASSACHUSETTS (USA)
SQ Innovation, Inc. is a Swiss biopharmaceutical company founded in 2019 with a presence in Switzerland, the USA, and the Netherlands. The company specializes in developing therapies for subcutaneous drug delivery, aiming to facilitate at-home ...
Lasix ONYU is an advanced prescription drug-device combination designed specifically for the treatment of edema in adults suffering from chronic heart failure. This innovative product represents a ...